219 related articles for article (PubMed ID: 2702249)
1. Pancreatic enzyme replacement therapy in post-pancreatectomy patients.
Braga M; Cristallo M; De Franchis R; Mangiagalli A; Zerbi A; Agape D; Primignani M; Di Carlo V
Int J Pancreatol; 1989; 5 Suppl():37-44. PubMed ID: 2702249
[TBL] [Abstract][Full Text] [Related]
2. Correction of malnutrition and maldigestion with enzyme supplementation in patients with surgical suppression of exocrine pancreatic function.
Braga M; Cristallo M; De Franchis R; Mangiagalli A; Agape D; Primignani M; Di Carlo V
Surg Gynecol Obstet; 1988 Dec; 167(6):485-92. PubMed ID: 3187872
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
Dutta SK; Rubin J; Harvey J
Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacology for pediatricians. I. Pancreatic enzyme preparations, with special reference to enterically coated microspheres of pancrelipase.
Cho YW; Aviado DM
J Clin Pharmacol; 1981; 21(5-6):224-37. PubMed ID: 7021605
[No Abstract] [Full Text] [Related]
5. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis].
Zsíros J; Sólyom E
Orv Hetil; 1988 May; 129(19):995-9. PubMed ID: 3290773
[No Abstract] [Full Text] [Related]
7. [Differential therapy of exocrine pancreatic insufficiency--current aspects and future prospects of substitution therapy with pancreatic enzymes].
Löser C; Fölsch UR
Z Gastroenterol; 1995 Dec; 33(12):715-22. PubMed ID: 8585255
[TBL] [Abstract][Full Text] [Related]
8. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
Ansaldi-Balocco N; Santini B; Sarchi C
J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
[TBL] [Abstract][Full Text] [Related]
11. Postoperative management of patients with total exocrine pancreatic insufficiency.
Braga M; Zerbi A; Dal Cin S; De Franchis R; Malesci A; Di Carlo V
Br J Surg; 1990 Jun; 77(6):669-72. PubMed ID: 2383737
[TBL] [Abstract][Full Text] [Related]
12. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery.
Gubergrits N; Malecka-Panas E; Lehman GA; Vasileva G; Shen Y; Sander-Struckmeier S; Caras S; Whitcomb DC
Aliment Pharmacol Ther; 2011 May; 33(10):1152-61. PubMed ID: 21418260
[TBL] [Abstract][Full Text] [Related]
13. Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis.
Boyle BJ; Long WB; Balistreri WF; Widzer SJ; Huang N
Gastroenterology; 1980 May; 78(5 Pt 1):950-3. PubMed ID: 7380201
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two forms of enteric-coated pancrelipase In six teenagers with cystic fibrosis.
Warwick WJ; Budd JR
Clin Ther; 1982; 5(1):15-20. PubMed ID: 7127365
[TBL] [Abstract][Full Text] [Related]
15. [Dose-dependent effect of pancreatin replacement upon the pancreatic function in the period after pancreatic surgery].
Farkas G; Leindler L; Mihalovits G
Magy Seb; 2001 Dec; 54(6):347-50. PubMed ID: 11816130
[TBL] [Abstract][Full Text] [Related]
16. [Effect of pancreatin replacement on pancreatic function in the postoperative period after pancreatic surgery].
Farkas G; Takács T; Baradnay G; Szász Z
Orv Hetil; 1999 Dec; 140(49):2751-4. PubMed ID: 10628192
[TBL] [Abstract][Full Text] [Related]
17. Oral pancreatic enzyme substitution therapy in chronic pancreatitis: is clinical response an appropriate marker for evaluation of therapeutic efficacy?
Domínguez-Muñoz JE; Iglesias-García J
JOP; 2010 Mar; 11(2):158-62. PubMed ID: 20208327
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2-antagonists, and enteric coating.
Marotta F; O'Keefe SJ; Marks IN; Girdwood A; Young G
Dig Dis Sci; 1989 Mar; 34(3):456-61. PubMed ID: 2563963
[TBL] [Abstract][Full Text] [Related]
20. Combining unprotected pancreatic enzymes with pH-sensitive enteric-coated microspheres does not improve nutrient digestion in patients with cystic fibrosis.
Kalnins D; Corey M; Ellis L; Durie PR; Pencharz PB
J Pediatr; 2005 Apr; 146(4):489-93. PubMed ID: 15812451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]